Biweekly paclitaxel as second-line treatment in advanced non-small-cell-lung-cancer (NSCLC).: A phase II study of the Galician Lung Cancer Group

被引：0
|
作者：
Vazquez-Estevez, S. [1 ]
Firvida, J. L. [2 ]
Grande, C. [3 ]
Baron, F. [4 ]
Lazaro, M. [5 ]
Salgado, M. [2 ]
Campos, B. [1 ]
Casal, J. [3 ]
Perez, E. [2 ]
Mel, J. R. [1 ]
机构：
[1] Complexo Hosp Xeral Calde, Lugo, Spain
[2] Complexo Hosp Ourense, Orense, Spain
[3] Hosp Meixoeiro, Vigo, Spain
[4] Complexo Hosp Univ Santiago, Santiago De Compostela, Spain
[5] Complexo Hosp Xeral Cies, Vigo, Spain
来源：
EJC SUPPLEMENTS | 2007年 / 5卷 / 04期
关键词：
D O I：
10.1016/S1359-6349(07)71443-X
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6615
引用
收藏
页码：392 / 392
页数：1
相关论文
共 50 条
  • [21] Biweekly Vinorelbine and Gemcitabine as Second-Line Treatment and Beyond in Non-Small Cell Lung Cancer
    Chelis, L.
    Xenidis, N.
    Amarantidis, K.
    Prassopoulos, P.
    Chamalidou, E.
    Neanidis, K.
    Mikroulis, D.
    Chatzaki, E.
    Karakitsos, P.
    Kakolyris, S.
    CHEMOTHERAPY, 2010, 56 (05) : 353 - 358
  • [22] SECOND-LINE CHEMOTHERAPY (CT) WITH DOCETAXEL IN ELDERLY ADVANCED NON-SMALL-CELL LUNG CANCER (NSCLC) PATIENTS: A PHASE II STUDY
    Bernardini, I.
    Tibaldi, C.
    Chella, A.
    Galli, L.
    Russo, F.
    Toma, G.
    Tempestini, F.
    Santolicandro, A. M.
    Coltelli, L.
    Falcone, A.
    ANNALS OF ONCOLOGY, 2004, 15 : 34 - 34
  • [23] Phase II trial of temozolomide and irinotecan as second-line treatment for advanced non-small cell lung cancer
    Choong, Nicholas W.
    Mazcer, Ann M.
    Hoffman, Philip C.
    Rudin, Charles M.
    Winegarden, Jerome D., III
    Villano, J. Lee
    Kozloff, Mark
    Wade, James L., III
    Sciortino, David F.
    Szeto, Livia
    Vokes, Everett E.
    JOURNAL OF THORACIC ONCOLOGY, 2006, 1 (03) : 245 - 251
  • [24] Phase II study of biweekly Gemcitabine and Docetaxel as first line treatment for advanced disease in elderly Non Small Cell Lung Cancer (NSCLC) patients
    Munoz-Langa, Jose
    Sanchez-Hernandez, Alfredo
    Gomez-Codina, Jose
    Esquerdo, Gaspar
    Catot, Silvia
    Macia, Sonia
    Juan, Oscar
    Giner, Vicente
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S700 - S701
  • [25] A phase II study of docetaxel (D) and gemcitabine (G) as second-line treatment in patients (pts) with advanced non-small cell lung cancer (NSCLC)
    Agelaki, S
    Papadakis, E
    Tsiafaki, X
    Rapti, A
    Toubis, M
    Bania, E
    Kalbakis, K
    Kouroussis, C
    Androulakis, N
    Georgoulias, V
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S256 - S256
  • [26] Phase I/II study of GTI-2040 plus docetaxel as second-line treatment in advanced non-small cell lung cancer (NSCLC)
    Leighl, N
    Laurie, S
    Knox, J
    Ellis, P
    Shepherd, F
    Burkes, R
    Pond, G
    Zwiebel, J
    Moore, M
    LUNG CANCER, 2005, 49 : S256 - S256
  • [27] A phase II study of biweekly paclitaxel and carboplatin in elderly patients with advanced non-small cell lung cancer
    Soejima, Kenzo
    Naoki, Katsuhiko
    Ishioka, Kota
    Nakamura, Morio
    Nakatani, Michie
    Kawada, Ichiro
    Watanabe, Hideo
    Nakachi, Ichiro
    Yasuda, Hiroyuki
    Satomi, Ryosuke
    Nakayama, Sohei
    Yoda, Satoshi
    Ikemura, Sinnosuke
    Terai, Hideki
    Sato, Takashi
    Ohgino, Keiko
    Arai, Daisuke
    Tani, Tetsuo
    Kuroda, Aoi
    Nishino, Makoto
    Betsuyaku, Tomoko
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2015, 75 (03) : 513 - 519
  • [28] Second-line treatment options in advanced non-small cell lung cancer
    de Marinis, Filippo
    Ricciardi, Serena
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S258 - S271
  • [29] ERLOTINIB AS SECOND-LINE TREATMENT FOR PATIENTS WITH ADVANCED NON-SMALL-CELL LUNG CANCER AND NON-SQUAMOUS HISTOLOGY: A GALICIAN LUNG CANCER GROUP STUDY (GGCP041/09)
    Vazquez, S.
    Casal, Joaquin
    Firvida, J. L.
    Lazaro, Martin
    Varela, S.
    Jose Villanueva, Maria
    Garcia-Lopez, Jesus
    Campos, Begona
    Grande, C.
    Fernandez, Ovidio
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1297 - S1297
  • [30] A phase II study of biweekly paclitaxel and carboplatin in elderly patients with advanced non-small cell lung cancer
    Kenzo Soejima
    Katsuhiko Naoki
    Kota Ishioka
    Morio Nakamura
    Michie Nakatani
    Ichiro Kawada
    Hideo Watanabe
    Ichiro Nakachi
    Hiroyuki Yasuda
    Ryosuke Satomi
    Sohei Nakayama
    Satoshi Yoda
    Sinnosuke Ikemura
    Hideki Terai
    Takashi Sato
    Keiko Ohgino
    Daisuke Arai
    Tetsuo Tani
    Aoi Kuroda
    Makoto Nishino
    Tomoko Betsuyaku
    Cancer Chemotherapy and Pharmacology, 2015, 75 : 513 - 519
12345